Clinical Trials
19
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (18 trials with phase data)โข Click on a phase to view related trials
A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
- First Posted Date
- 2017-11-08
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 21
- Registration Number
- NCT03336580
- Locations
- ๐บ๐ธ
Tufts Medical Center, Boston, Massachusetts, United States
๐บ๐ธMayo Clinic Minnesota, Rochester, Minnesota, United States
๐บ๐ธOregon Health and Science University, Portland, Oregon, United States
Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis
- First Posted Date
- 2015-12-15
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 48
- Registration Number
- NCT02630901
- Locations
- ๐บ๐ธ
TCR Medical Corporation, San Diego, California, United States
๐บ๐ธUniversal Medical and Research Center, LLC, Coral Gables, Florida, United States
๐บ๐ธRenstar Medical Research, Ocala, Florida, United States
Single Ascending Dose Study of PRX003 in Healthy Subjects
- First Posted Date
- 2015-06-01
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 40
- Registration Number
- NCT02458677
- Locations
- ๐บ๐ธ
Worldwide Clinical Trials Early Phase Services, San Antonio, Texas, United States
Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease
- First Posted Date
- 2014-06-06
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 64
- Registration Number
- NCT02157714
- Locations
- ๐บ๐ธ
Collaborative Neuroscience Network, LLC, Long Beach, California, United States
๐บ๐ธInstitute for Neurodegenerative Disorders, New Haven, Connecticut, United States
๐บ๐ธParkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, United States
Single Ascending Dose Study of PRX002 in Healthy Subjects
- First Posted Date
- 2014-03-24
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Prothena Biosciences Limited
- Target Recruit Count
- 40
- Registration Number
- NCT02095171